165 related articles for article (PubMed ID: 7894881)
1. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions.
Hawley CJ; Roberts AG; Baldwin DS
Int Clin Psychopharmacol; 1994; 9(1):31-3. PubMed ID: 8195580
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Katona CL; Robertson MM; Abou-Saleh MT; Nairac BL; Edwards DR; Lock T; Burns R; Harrison DA; Taylor NS
Int Clin Psychopharmacol; 1993; 8(4):323. PubMed ID: 8277156
[No Abstract] [Full Text] [Related]
4. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
Flint AJ; Rifat SL
J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
[TBL] [Abstract][Full Text] [Related]
5. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
Fava M; Rosenbaum JF; McGrath PJ; Stewart JW; Amsterdam JD; Quitkin FM
Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".
Taragano FE; Bagnatti P; Allegri RF
Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380
[TBL] [Abstract][Full Text] [Related]
7. Capgras syndrome in association with lithium toxicity.
Canagasabey B; Katona CL
Br J Psychiatry; 1991 Dec; 159():879-81. PubMed ID: 1790464
[TBL] [Abstract][Full Text] [Related]
8. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
Fontaine R; Ontiveros A; Elie R; Vézina M
Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782
[No Abstract] [Full Text] [Related]
9. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
[TBL] [Abstract][Full Text] [Related]
10. Refractory depression: a review with particular reference to the use of lithium augmentation.
Katona CL
Eur Neuropsychopharmacol; 1995; 5 Suppl():109-13. PubMed ID: 8775769
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
[TBL] [Abstract][Full Text] [Related]
12. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Lancaster SG; Gonzalez JP
Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
[TBL] [Abstract][Full Text] [Related]
13. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
Bloch M; Schwartzman Y; Bonne O; Lerer B
J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
[TBL] [Abstract][Full Text] [Related]
14. The comparative antidepressant value of lofepramine and amitriptyline. Results of a controlled trial with comments on the scales used.
McClelland HA; Kerr TA; Stephens DA; Howell RW
Acta Psychiatr Scand; 1979 Aug; 60(2):190-8. PubMed ID: 388988
[TBL] [Abstract][Full Text] [Related]
15. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
Heninger GR; Charney DS; Sternberg DE
Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
Joffe RT; Singer W; Levitt AJ; MacDonald C
Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
[TBL] [Abstract][Full Text] [Related]
17. Refractory depression: the addition of lithium to fluoxetine or desipramine.
Ontiveros A; Fontaine R; Elie R
Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
[TBL] [Abstract][Full Text] [Related]
18. The effect of sequential antidepressant treatment on geriatric depression.
Flint AJ; Rifat SL
J Affect Disord; 1996 Jan; 36(3-4):95-105. PubMed ID: 8821312
[TBL] [Abstract][Full Text] [Related]
19. Lithium carbonate versus cognitive therapy as sequential combination treatment strategies in partial responders to antidepressant medication: an exploratory trial.
Kennedy SH; Segal ZV; Cohen NL; Levitan RD; Gemar M; Bagby RM
J Clin Psychiatry; 2003 Apr; 64(4):439-44. PubMed ID: 12716247
[TBL] [Abstract][Full Text] [Related]
20. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
